Advanced Search


Study ID Status Title Patient Level Data
116402 Completed A multi-national, randomized, double-blind, placebo-controlled, 3-period crossover study with GSK 573719 as monotherapy in adult subjects with asthma Study Listed on
116404 Completed Sleepiness and mood in Parkinson's disease and combination treatment with ropinirole and levodopa
116406 Completed A study to test the possibility of cross reaction of the antibodies induced by the ELAPRASE (R) to GSK2788723ELAPRASE is a trade mark owned by a third party
116409 Completed An open-label, randomised, cross-over, single centre study in healthy volunteers to optimise the Rotacap formulation andROTAHALER device for delivery of Fluticasone propionate/salmeterol.
116415 Completed A randomized, double-blind, single dose, four way cross-over study to assess the systemic exposure, systemic pharmacodynamics and safety and tolerability of FluticasoneFuroate, Umeclidinium and Vilanterol following single inhaled doses of Umeclidinium/Vilanterol blend + Fluticasone Furoate, Umeclidinium + Vilanterol, Fluticasone Furoate + Vilanterol and Fluticasone Furoate + Umeclidinium in healthy subjects Study Listed on
116416 Completed Single and Repeat Dose Pharmacokinetic Study of GSK1605786 in Healthy Chinese Subjects Study Listed on
116427 Completed An observer-blind study to evaluate immunogenicity and safety of GSK Biologicals’ Herpes Zoster vaccine GSK1437173A in adults 18 years of age or older with solid tumours receiving chemotherapy
116428 Completed Study to evaluate safety and immunogenicity of GSK Biologicals' Herpes Zoster vaccine GSK1437173A in adults aged 18 years and older with haematologic malignancies
116429 Completed Prospective cohort study for patients’ adherence on lower urinary tract symptoms (LUTS) / Benign prostatic hyperplasia (BPH) pharmacological treatment in real practice
116431 Completed An Open-Label Study to Determine the Safety and Pharmacokinetics of AT1001 in Subjects with Impaired Renal Function and Healthy Subjects with Normal Renal Function (AT1001-015)
116435 Completed A Phase 1 Study to Investigate the Absorption, Metabolism and Excretion of [14C] AT1001 (migalastat hydrochloride) following a Single Oral Administration in Healthy Volunteers (AT1001-014)
116439 Completed A study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2586184 following a single doseof 800mg and repeat oral tablet doses of 800mg b.d and the effect of food and gender on the pharmacokinetics of oralGSK2586184 in healthy subjects
116441 Completed Single Oral Dose Study of Atovaquone/Proguanil Hydrochloride Combination Tablets and Atovaquone Suspension. - A Single Oral Dose Study to Investigate Pharmacokinetics of Atovaquone and Proguanil from Combination Tablets and Atovaquone from Atovaquone Suspension in Japanese Healthy Males. -
116454 Active, Not Recruiting Special Drug Use Investigation for ReQuip® Controlled-Release (CR)
116455 Completed A Multi-Center, Open-labelled Study to Evaluate the Safety of Levocetirizine Hydrochloride Oral Solution in Children Aged 6 Months to 2 Years with Allergic Rhinitis or Pruritus Associated with the Skin Diseases.
116456 Recruiting A Post-Marketing Surveillance Study of Requip PD™ (Ropinirole) in the Treatment of Adult Filipino Patients diagnosed with Parkinson’s Disease
116457 Terminated An open-label extension study of the long-term safety, tolerability and efficacy of ambrisentan in subjects with inoperable chronic thromboembolic pulmonary hypertension (CTEPH)
116459 Completed Pharmacokinetic Study of Levocetirizine Oral Solution-An open-label, randomized, cross-over study to evaluate the pharmacokinetics, the safety and tolerability of levocetirizine oral solution (5 mg) and cetirizine dry syrup (10 mg), following a single dose in Japanese healthy male subjects-
116460 Recruiting Drug Use Investigation of SAMTIREL (atovaquone) Oral Suspension 15%
116461 Active, Not Recruiting Drug Use Investigation of VOTRIENT Tablets
116472 Completed BEL116472. A 2 year mechanistic study of belimumab in Idiopathic Membranous Glomerulonephropathy
116477 Completed Proof of Mechanism Study to Assess the Potential of GSK239512 to Remyelinate Lesions in Subjects with Relapsing Remitting Multiple Sclerosis Study Listed on
116480 Completed An open label, balanced, randomized, three-treatment, three-period, six-sequence, cross-over, single dose, comparative bioavailability pilot study of two test formulations of fixed dose combination capsules of acetylsalicylic acid (ASA) and pantoprazole (Each capsule contains ASA 100 mg and pantoprazole 20 mg) manufactured by Piramal Healthcare Limited, India for GSK comparing with Aspirin® Protect 100 mg tablets by Bayer vital GmbH, and Protium® 20 mg gastro-resistant tablets by Nycomed GmbH, in healthy, adult, human subjects, under fasting conditions Study Listed on
116482 Active, Not Recruiting A Phase IIb, dose ranging study of oral GSK1265744 in combination with nucleoside reverse transcriptase inhibitors for induction of human immunodeficiency virus -1 (HIV-1) virologic suppression followed by an evaluation of maintenance of virologic suppression when oral GSK1265744 is combined with oral rilpivirine in HIV-1 infected, antiretroviral therapy naive adult subjects
116483 Recruiting Protocol to evaluate the public health value of maraviroc using the French hospital databaseon HIV infection (FHDH)



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.